ClinicalTrials.Veeva

Menu

Insomnia in Postmenopausal Osteoporosis

B

Beylikduzu State Hospital

Status

Completed

Conditions

Osteoporosis

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT06646549
Beylikdüzüstateh4

Details and patient eligibility

About

Aim of the study was to determine the presence of sleep problems in postmenopausal osteoporosis patients and to examine the relationship between the severity of insomnia and mood and fatigue. Pain, sleep problems, depression, anxiety, and fatigue were assessed using appropriate scales

Full description

The research was planned as a clinical cross-sectional study. Two hundred women, aged between 50-75 years, who were diagnosed with postmenopausal osteoporosis and followed up in the outpatient clinics of Beylikdüzü State Hospital and Istanbul Physical Medicine and Rehabilitation Training and Research Hospital between May 19, 2024, and June 19, 2024, were included. Sociodemographic data such as gender, height, weight, body mass index, educational status, and occupation were recorded. The date of osteoporosis diagnosis, history of falls within the last 6 months, presence of fractures due to low-energy trauma, osteoporosis treatment, medications used, and comorbidities were questioned. The presence and location of pain were asked, and if pain was present, its intensity was determined using the Visual Analog Scale. Calcium and vitamin D levels from the last 3 months were recorded. The patient's sleep problems were assessed using the Insomnia Severity Index. Subsequently, the patient's current depression and anxiety-related symptoms were measured using the Hospital Anxiety and Depression Scale (HADS), and the fatigue level was assessed with the Fatigue Severity Scale (FSS).

Enrollment

200 patients

Sex

Female

Ages

50 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women diagnosed with postmenopausal osteoporosis.
  • Patients who agreed to participate in the study.
  • Age range between 50-75 years.

Exclusion criteria

  • Presence of fibromyalgia.
  • Chronic fatigue syndrome.
  • Chronic decompensated cardiac, renal, or hepatic failure.
  • Known psychiatric disorders.
  • Rheumatological diseases.
  • Presence of other known neurological diseases.
  • Use of medications that enhance physical performance or alleviate fatigue.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems